Cardio Diagnostics Holdings, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Cardio Diagnostics Holdings, Inc. (CDIO) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$232.59 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$93.96K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$138.63K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$96.32K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$162.89K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$479.97K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$915.97K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$758.67K, a 209.82% decline from fiscal 2022.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $690.82K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$93.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$232.59K 10-Q · filed 2026-08-07 | -$328.91K derived: sum of 3 quarters · filed 2026-08-07 | -$491.80K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$138.63K 10-Q · filed 2026-05-15 | -$234.95K derived: sum of 2 quarters · filed 2026-05-15 | -$397.84K derived: sum of 3 quarters · filed 2026-05-15 | -$511.14K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$96.32K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$259.21K derived: sum of 2 quarters · filed 2026-03-13 | -$372.51K derived: sum of 3 quarters · filed 2026-08-07 | -$479.97K 10-K · filed 2026-03-13 |
| 2025-09-30 | -$162.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$276.19K derived: sum of 2 quarters · filed 2026-08-07 | -$383.65K 10-Q · filed 2025-11-12 | -$452.90K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$113.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$220.76K 10-Q · filed 2026-08-07 | -$290.02K derived: sum of 3 quarters · filed 2026-08-07 | -$480.42K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$107.46K 10-Q · filed 2026-05-15 | -$176.72K derived: sum of 2 quarters · filed 2026-05-15 | -$367.12K derived: sum of 3 quarters · filed 2026-05-15 | -$553.38K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$69.25K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$259.66K derived: sum of 2 quarters · filed 2026-03-13 | -$445.92K derived: sum of 3 quarters · filed 2026-03-13 | -$915.97K 10-K · filed 2026-03-13 |
| 2024-09-30 | -$190.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$376.67K derived: sum of 2 quarters · filed 2025-11-12 | -$846.72K 10-Q · filed 2025-11-12 | -$729.32K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$186.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$656.31K 10-Q · filed 2025-08-14 | -$538.91K derived: sum of 3 quarters · filed 2025-08-14 | -$855.95K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$470.05K 10-Q · filed 2025-05-15 | -$352.65K derived: sum of 2 quarters · filed 2025-05-15 | -$669.69K derived: sum of 3 quarters · filed 2025-05-15 | -$890.61K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $117.40K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$199.64K derived: sum of 2 quarters · filed 2025-03-20 | -$420.56K derived: sum of 3 quarters · filed 2025-03-20 | -$758.67K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$317.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$537.96K derived: sum of 2 quarters · filed 2024-11-13 | -$876.07K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$220.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$559.03K 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | -$338.11K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $690.82K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |